関連する実験動画
Updated: Aug 14, 2026

11:44
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
細胞生存とNF-kappaB活性化におけるグリコゲン合成酵素キナーゼ-3βの要件
K P Hoeflich1, J Luo, E A Rubie
1Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Canada.
Nature
|July 14, 2000
まとめ
グリコーゲン合成キナーゼ-3β (GSK-3β) 欠乏症は,過剰な腫瘍死滅因子 (TNF) 毒性による肝損傷による胚死亡を引き起こす. GSK-3βは核因子-kappaB (NF-kappaB) 機能を促進し,TNF誘発細胞死から保護する.
科学分野:
- 分子生物学は分子生物学である.
- 発達生物学 発達生物学とは
- 免疫学 免疫学とは
背景:
- グリコーゲン合成キナーゼ-3 (GSK-3) のアルファとベータの同型は,Wnt信号伝達と細胞増殖の主要な調節因子である.
- モデル生物における以前の研究では,GSK-3の生理学的役割に関する洞察が得られた.
研究 の 目的:
- 哺乳類の胚発達におけるGSK-3βの機能を調査する.
- 腫瘍死滅因子 (TNF) と核因子-kappaB (NF-kappaB) 信号伝達経路の調節におけるGSK-3βの役割を明らかにする.
主な方法:
- ネズミのGSK-3βの遺伝子破壊.
- 胚の死亡率と肝臓変性現象の分析.
- 抗TNF-α抗体を用いてTNFを阻害する.
- TNF-alphaに対するフィブロブラストの感受性の評価.
- GSK-3β欠乏細胞におけるNF-kappaBの活性化と機能の評価.
- GSK-3の活性を抑制するリチウム治療.
主要な成果:
- GSK-3βの破壊は,過度のTNF毒性を模倣して,重度の肝変性を持つ胚の致死につながる.
- GSK-3β欠乏胚は,抗TNF-α抗体治療によって救われます.
- GSK-3βが欠けている線維芽細胞は,TNF-αに対する過敏性とNF-kappaB機能の障害を示します.
- リチウム処理はNF-kappaBのトランザクティベーションを阻害し,野生型の細胞をTNFに敏感にします.
- GSK-3βは,早期の活性化段階ではなく,転写複合体レベルでNF-kappaBを調節する.
結論:
- GSK-3βは,TNFの毒性を軽減することによって,胚の致死性を予防する上で重要な役割を果たします.
- GSK-3βは,適切なNF-kappaB機能に不可欠であり,I-kappaBの分解とNF-kappaBの核転移の後方に作用する.
- GSK-3βはNF-kappaB媒介の転写調節を促進し,発達過程と細胞保護におけるその重要性を強調しています.
さらに関連する動画
関連する概念動画
GTPases and their Regulation
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Large G-proteins, also known...
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

